ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo as Postoperative Adjuvant Treatment for Pathological Stage III G/GEJ Cancer"

365 views
June 14, 2023
0 Comments
Login to view comments. Click here to Login